Dr. Douglas Marshall Engh, FACS, MD

Dr. Engh practices at Helm Vision Group in Valencia, California.

Dr. Engh's NPI, 1538249099, was assigned on October 17, 2006. Dr. Engh graduated from David Geffen School of Medicine at UCLA in 1982. Dr. Engh holds California license G50142.

Dr. Engh's primary practice is Helm Vision Group, at 27420 Tourney Rd Suite 100 Suite 100, Valencia, CA 91355-5631. The practice phone is (661) 259-3937.

Dr. Engh's primary practice is Helm Vision Group in Valencia, California. Dmand AI also links Dr. Engh to 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Engh practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Engh's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Engh is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Engh's licenses on file in 3 states: California, Colorado and Hawaii.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation, glaucoma and inflammation of iris among the conditions Dr. Engh treats.

CMS data shows 644 Medicare services from Dr. Engh across 12 procedure codes in 2024, for 249 Medicare patients. Medicare paid $34,898 for them. Every service was in an office.

CMS counts 249 Medicare patients who saw Dr. Engh in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Engh's median patient age at 74, with 46% women.

In 2024, Dr. Engh wrote 650 Medicare Part D claims for 233 patients. 61% of them were for generic drugs. CMS names the drug for 547 of them, across 9 drugs with 11 or more claims each, at $18,678 in total drug cost. In 2023, CMS named 1,303 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Engh for performance year 2024, reported as part of a group.

Dmand AI links 7 papers to Dr. Engh, published from 2001 to 2011. 2002 was the busiest year, with 2. Dr. Engh has published most often in Phys Rev Lett. Dr. Engh's most frequent co-authors are Christopher Calabria, MD, Jonathan E. Efron, MD and Sheldon Goldberg, MD.

CMS Open Payments shows 91 general payments to Dr. Engh from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Shire North American Group Inc paid the most, $592.

Dmand AI lists 2 awards for Dr. Engh.

Dr. Engh graduated from David Geffen School of Medicine at UCLA in 1982. Dr. Engh is a member of AAO and ACS.

Dr. Engh is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.